WEIGAO GROUP Profit Falls 22%, Dividend Cut Sharply

Edgen Stock·Mar 27 2026, 09:34

Share to

Share to

Copy link

Key Takeaways

WEIGAO GROUP reported a significant 22% drop in full-year 2025 net profit despite a modest revenue increase, prompting the company to slash its final dividend by more than half. The results point to considerable margin pressure and a cautious outlook from management.

Full-year 2025 net profit fell 22% year-over-year to RMB 1.612 billion.
Revenue grew slightly by 2.3% to RMB 13.389 billion, indicating a sharp contraction in profitability.
The company slashed its final dividend to RMB 0.06 per share, down from RMB 0.1235 in the prior year.

Profitability Contracts 22% Despite Sales Growth

WEIGAO GROUP (01066.HK) announced a significant downturn in profitability for the full year ending in December 2025. The company's net profit fell 22% year-over-year to RMB 1.612 billion, yielding an earnings per share of RMB 0.36. This profit decline occurred even as revenue posted a modest gain of 2.3%, reaching RMB 13.389 billion for the year. The divergence between top-line growth and bottom-line results suggests the medical device manufacturer faced substantial pressure on its margins, likely from rising operational costs or pricing challenges within its markets.

Final Dividend Slashed by Over 50%

Reflecting the weakened earnings, WEIGAO's board declared a final dividend of RMB 0.06 per share. This represents a steep reduction of more than 51% compared to the final dividend of RMB 0.1235 paid in the same period last year. The decision to cut shareholder payouts so drastically signals a strategic move by management to conserve cash in response to deteriorating financial performance. For investors, this action raises concerns about the company's near-term earnings power and its ability to navigate the underlying business headwinds that compressed its 2025 profits.